Bayer Canada Backs a Transformative Step in Medical Education
Bayer Canada has announced a significant initiative to support the launch of the new School of Medicine at Simon Fraser University (SFU). This collaboration marks a major milestone in advancing healthcare education and addressing long-standing gaps in access to primary care in British Columbia.
The new medical school represents the first of its kind in Western Canada in nearly six decades, underscoring the urgency and importance of expanding medical training capacity in the region. With a clear focus on community-based care and inclusivity, the initiative aims to shape a new generation of physicians who are better equipped to serve diverse and underserved populations.
Addressing a Critical Healthcare Shortage
British Columbia is currently facing a pressing shortage of family doctors, leaving approximately 800,000 residents without access to a primary care physician. This gap has placed significant strain on the healthcare system and highlighted the need for innovative solutions in medical education and workforce development.
SFU’s new School of Medicine has been designed specifically to address this challenge. By prioritizing the training of family physicians and embedding students within community healthcare settings early in their education, the program aims to produce graduates who are more likely to remain in the province and serve where they are needed most.
The collaboration with Bayer Canada strengthens this mission by helping remove financial barriers that often prevent talented individuals from pursuing a medical career.
Launch of the Inaugural Class
SFU is preparing to welcome its first cohort of 48 students in the upcoming summer term. The inaugural class will begin their studies at an interim facility located on the university’s Surrey campus. Plans are already underway for a state-of-the-art, purpose-built medical education facility in Surrey City Centre, expected to open by 2030.
This phased approach allows the university to begin training future physicians immediately while building long-term infrastructure to support the program’s growth.
What sets this program apart is its accelerated, hands-on learning model. Students will begin clinical training just one month after starting their studies, gaining real-world experience in clinics, hospitals, and community practices across the province. This early exposure is intended to strengthen practical skills and foster meaningful connections with the communities they will eventually serve.
The Bayer Entrance Award: Removing Financial Barriers
A cornerstone of Bayer Canada’s support is the introduction of the Bayer Entrance Award. This prestigious award will cover the full tuition costs for one student throughout the three-year medical program.
The recipient will be selected based on a combination of academic excellence, demonstrated leadership, community service, and financial need. By aligning the selection criteria with its broader values, Bayer aims to support students who are not only capable but also deeply committed to making a difference in healthcare.
Applicants who reach the interview stage for SFU’s MD program will receive detailed instructions on how to apply for the award. This ensures that the opportunity is accessible to those who have already demonstrated strong potential for success in the field.
The award reflects Bayer’s ongoing commitment to fostering diversity and inclusion in healthcare by supporting students from underrepresented backgrounds and helping them overcome financial obstacles.
A Shared Vision for Accessible Healthcare
According to Viktoria Friedrich, General Manager of Bayer Canada’s Pharmaceutical Division, access to quality healthcare is a fundamental right. She emphasized that the partnership with SFU is a meaningful step toward addressing the urgent need for family doctors in the province.
By investing in the education of future physicians, Bayer is not only supporting individual students but also contributing to the long-term health of communities across British Columbia. The initiative is particularly focused on empowering students from underrepresented groups, ensuring that the healthcare workforce better reflects the diversity of the population it serves.
Commitment to Community-Based Training
SFU’s School of Medicine has been intentionally structured to prioritize community engagement and real-world experience. The program actively seeks to admit students from rural, remote, Indigenous, and underserved communities—groups that are often disproportionately affected by healthcare shortages.
By training students within these communities, the program aims to build lasting connections and encourage graduates to continue practicing in these areas after completing their education. This approach is widely recognized as an effective strategy for improving healthcare access in underserved regions.
Samir Malhotra, Associate Dean of Learners at SFU’s School of Medicine, highlighted the importance of this support. He noted that financial assistance like the Bayer Entrance Award enables students to focus fully on their training and their commitment to serving communities in need.
He also emphasized the school’s dedication to team-based, community-centered care—an approach that is essential for addressing persistent gaps in healthcare access.
Strengthening Diversity and Inclusion in Medicine
The collaboration between Bayer Canada and SFU goes beyond financial support. It reflects a shared commitment to creating a more inclusive healthcare system by expanding opportunities for students from diverse backgrounds.
Historically, barriers such as high tuition costs and limited access to resources have prevented many capable individuals from pursuing medical education. By offering full-tuition support to one student and fostering an inclusive admissions approach, this initiative helps level the playing field.
Bayer has also expressed its broader commitment to supporting students throughout their journey—from STEM education to medical school and into their professional careers. This long-term perspective ensures that investments made today will continue to benefit healthcare systems in the future.
Long-Term Impact on Healthcare in British Columbia
The establishment of SFU’s School of Medicine, combined with Bayer Canada’s support, has the potential to create lasting change in British Columbia’s healthcare landscape.
By increasing the number of trained physicians, particularly in primary care, the program aims to reduce the number of residents without access to a family doctor. At the same time, its emphasis on community-based training and diversity ensures that care is more equitable and culturally responsive.
The Bayer Entrance Award serves as a powerful example of how targeted financial support can make a meaningful difference—not only in the life of an individual student but also in the health outcomes of entire communities.
As SFU prepares to welcome its inaugural class, the partnership with Bayer Canada sets a strong foundation for the future. Together, they are addressing immediate challenges while building a sustainable model for medical education and healthcare delivery.
This initiative demonstrates how collaboration between academic institutions and industry leaders can drive meaningful progress. By investing in education, removing barriers, and prioritizing community needs, Bayer Canada and SFU are helping to shape a healthcare system that is more accessible, inclusive, and resilient.
In the years to come, the impact of this collaboration will be measured not only in the number of physicians trained but also in the improved health and well-being of communities across British Columbia.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2025, the Group employed around 88,000 people and had sales of 45.6 billion euros. R&D expenses amounted to 5.8 billion euros.
About Simon Fraser University
SFU is a leading research university, advancing an inclusive and sustainable future. Over the past 60 years, SFU has been recognized among the top universities worldwide in providing a world-class education and working with communities and partners to develop and share knowledge for deeper understanding and meaningful impact. Committed to excellence in everything we do, SFU fosters innovation to address global challenges and continues to build a welcoming, inclusive community where everyone feels a sense of belonging. With campuses in British Columbia’s three largest cities—Burnaby, Surrey and Vancouver—SFU has ten faculties that deliver 368 undergraduate degree programs and 149 graduate degree programs for more than 37,000 students each year. The university boasts more than 200,000 alumni residing in 145+ countries
